Pterygium Clinical Trial
Official title:
Assessment of Low-temperature Plasma Surgery System in Pterygium With Fibrin Glue and Conjunctival Autografts
Verified date | June 2017 |
Source | Zhongshan Ophthalmic Center, Sun Yet-san University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Pterygium is a wing-shaped fibrovascular tissue that has proliferated onto the cornea. Ultraviolet radiation and hot, dusty, windy, dry, smoky environments are regarded as risk factors for pterygium . Surgical removal is the treatment of choice, and surgical wound intraoperative and inflammatory response postoperative have been considered two of the most significant factors that can increase the recurrence rate of pterygium. Low-Temperature Plasma Surgery System(LTP), avoids causing burn injuries to patients, has been introducing into minimally invasive surgery. The mechanism by which this equipment stop bleeding and abolish tissue is to directly occupy the injury with the formed blood clots, plasma flows close the vessel and plasma active particles cause physical and chemical reactions with tissue. The different levels of energy density of plasma can affect the bacteria, cells and cancer cells and even to death, therefore it is widely used in the disinfection of medical devices, dental root canal therapy, skin disease treatment and surgical wound disinfection. Whether it's possible to apply the advantages and benefits of plasma technology in ophthalmic surgery? Like pterygium surgery? However, there is no research to answer until now. In this study, the investigators retrospectively observed the efficacy, postoperative discomfort, inflammation, complications, and recurrence rates in a group of patients for whose LTP was used in pterygium excision and wound hemostasis. The investigators Observe the clinical benefits of LTP in pterygium surgery and find the facilitates and problems it need to be addressed reasonably.
Status | Completed |
Enrollment | 56 |
Est. completion date | April 2017 |
Est. primary completion date | February 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 40 Years to 80 Years |
Eligibility |
Inclusion Criteria: - all cases are primary pterygium,a follow-up period of more than 3 months after surgery Exclusion Criteria: - no immunorelated disease, ocular surface disease, glaucoma, or eyelid disease. Patients with recurrent pterygium were excluded from the study. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Zhongshan Ophthalmic Center, Sun Yet-san University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The changes of Best-corrected visual acuity (BCVA), | Non-contact ocular pressure measuring instrument | Before surgery,1-day, 1-week, 1-month, 3-month | |
Secondary | The changes of Patient's subjective discomfort evaluated in terms of the ocular symptom scores(OSS) | OSS including five kinds of subjective sensory scale of foreign body sensation, burning sensation, visual fatigue, dryness and eye pain. | Before surgery,1-day, 1-week, 1-month, 3-month | |
Secondary | conjunctival autograft inflammation | Inflammation Grade 0: No dilated corkscrew vessel in the graft Grade 1: 1 bright red, dilated corkscrew vessel crossing the graft-bed margin Grade 2: 2 bright red, dilated corkscrew vessels crossing the graft-bed margin Grade 3: three bright red, dilated corkscrew vessels crossing the graft-bed margin | 1-day, 1-week | |
Secondary | The changes of the ocular surface inflammation assessed by the Oculus Keratograph?R5M (Oculus Optikgerate GmbH, Wetzlar, Germany), with temporal conjunctival hyperaemia index(TCHI) | the ocular surface inflammation assessed by the Oculus Keratograph?R5M (Oculus Optikgerate GmbH, Wetzlar, Germany) | Before surgery, 1-week, 1-month, 3-month | |
Secondary | The postoperative complications were examined, including dehiscence, dislocation, sclera wound healing defects, granuloma and high intraocular pressure | Digital slit-lamp photography was performed during each postoperative visit | 1-week, 1-month, 3-month | |
Secondary | The recurrence | Digital slit-lamp photography was performed at 3-month | 3-month | |
Secondary | slit-lamp examination | Corneal epithelium healing | Before surgery,1-week, 1-month | |
Secondary | determination of intraocular pressure | Non-contact tonometer | Before surgery, 3-month | |
Secondary | The changes of Patient's subjective discomfort evaluated in terms of the visual analogue scale(VAS) by a questionnaire method | Visual Simulation Scoring (VAS): The method is more sensitive and comparable. The specific approach is: on the paper to draw a 10 cm horizontal line, one end of the horizontal line is 0, that painless; the other end is 10, that pain; the middle part of the different degrees of pain. Let the patient according to self-feeling in the horizontal line on a mark, that the degree of pain | Before surgery,1-day, 1-week, 1-month, 3-month | |
Secondary | The subconjunctival haemorrhage (SCH) | Subconjunctival haemorrhage | 1-day, 1-week | |
Secondary | graft stability according to scoring scale | Grade 0: None Grade 1: 25% of the size of the graft Grade 2: 50% of the size of the graft Grade 3: 75% of the size of the graft Grade 4: Haemorrhage involving the entire graft (no subconjunctival vessels visible Grade 4: >3 bright red, dilated corkscrew vessels crossing the graft-bed margin Graft stability Grade 0: All four sides of the graft margin are well apposed Grade 1: Gaping/displacement of one side of the graft-bed junction Grade 2: Gaping/displacement of two sides of the graft-bed junction Grade 3: Gaping/displacement of three sides of the graft-bed junction Grade 4: Graft completely displaced from the bed |
1-day, 1-week |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02641132 -
Pterygium Head Body MMC1: Two Different Surgical Procedures and Their Effect on Endothelial Cell Count.
|
Phase 4 | |
Completed |
NCT02342392 -
Intralesional Ranibizumab on Pterygium Vascularity, Size and Recurrence Rate: a Pilot Study
|
Phase 2/Phase 3 | |
Recruiting |
NCT01387971 -
Using Impression Cytology to Observe the Cytological Changes of Ocular Surface Cells in Various Ocular Surface Disorders
|
N/A | |
Recruiting |
NCT05978687 -
The Use of Lidocaine Gel Versus Subconjunctival Xylocaine Injection in Pterygium Excision
|
Phase 4 | |
Not yet recruiting |
NCT06042296 -
Expression of CD44, PCNA and E-cadherin in Pterygium Tissue
|
||
Completed |
NCT04022811 -
Effect of Bromfenac on Pain Related to Pterygium Surgery
|
Phase 4 | |
Recruiting |
NCT01261455 -
Prospective Randomized Pilot Study Comparing Inferior Versus Superior Conjunctival Autografts for Primary Pterygia
|
N/A | |
Recruiting |
NCT01249235 -
Bandage Contact Lens and Oral Analgesics Versus Patching and Oral Analgesics for Pain Following Pterygium Surgery
|
N/A | |
Completed |
NCT01115517 -
Safety Study of Avastin Used as Adjunctive Therapy in Pterygium Surgery
|
Phase 2 | |
Completed |
NCT00768963 -
Ranibizumab for the Inhibition of Neovascularization in Pterygia
|
Phase 1 | |
Completed |
NCT00949728 -
Conjunctival Autologous Transplantation Using Fibrin Glue in Primary Pterygia
|
N/A | |
Recruiting |
NCT00563277 -
Surgical Treatment of Concurrent Cataract and Primary Pterygium
|
N/A | |
Completed |
NCT00346450 -
Autologous ex Vivo Conjunctival Epithelial Cell Expansion for Ocular Surface Transplantation
|
Phase 3 | |
Completed |
NCT03533244 -
A Study of the Response to AG-86893 in Patients With Pterygium Hyperemia
|
Phase 2 | |
Completed |
NCT04403516 -
Dextenza in Pterygium Surgery
|
Phase 4 | |
Recruiting |
NCT02911532 -
Tissue Engineering Conjunctiva for the Treatment of Pterygium and Atretoblepharia
|
N/A | |
Not yet recruiting |
NCT03304366 -
Corneal Changes With Pentacam Before and After Pterygium
|
N/A | |
Unknown status |
NCT02015000 -
Surgical Result of Pterygium Extended Removal Followed by Fibrin Glue Assisted Amniotic Membrane Transplantation
|
N/A | |
Completed |
NCT00344201 -
Assessment of Fibrin Glue in Pterygium Surgery and Other Forms of External Eye Surgery
|
Phase 1 | |
Recruiting |
NCT00326560 -
Comparison of Glue With Sutures for Pterygium Surgery
|
Phase 3 |